Delivery Order SPE2DB22D2005-SPE2DB23FJUA4
Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $1.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,083 to Amerisourcebergen Drug Corporation to supply 200mg Xcopri tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required between September 19-20, 2023. The Defense Logistics Agency routinely utilizes indefinite-delivery/indefinite-quantity contracts to streamline the procurement of pharmaceuticals and...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,477.78 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packaging) on January 14, 2026. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. The delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 100 mg tablets (30-count package) valued at $1,218.35 under a firm fixed-price contract type. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-competitive, non-set-aside procurement. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,703.91 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,416 to Amerisourcebergen Drug Corporation. The order is for 30 tablets of the 200mg dosage of Xcopri, a prescription medication, to be delivered to a facility in Conshohocken, Pennsylvania by August 4, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor in fulfilling this order placed under an existing DLA contract...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $1,082.68 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 50 milligram Xcopri tablets. The delivery order, issued under an existing DLA medical supplies contract vehicle, calls for Amerisourcebergen to deliver 30 tablets to a facility in Conshohocken, Pennsylvania by July 10, 2023. No subcontractors or set aside designations were specified. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Xcopri 200 mg tablets (30-count packaging) under a firm fixed-price contract valued at $1,684.59. This is a non-set-aside award, indicating the contract was competitively bid. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,802.07 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,423.14 to AmerisourceBergen Drug Corp for 30-count bottles of Xcopri 150 mg tablets, with an ultimate completion date of November 19, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child purchase order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB23FJUA4Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,624 to Amerisourcebergen Drug Corporation to supply 50mg tablets of Xcopri. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation and will perform under the contract from its location in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. The delivery order was issued on September 7, 2023 under an existing DLA contract vehicle to fulfill the Agency's supply needs for this pharmaceutical product in support of its logistics and procurement missions.
Generated 12/20/23, 2:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/7/23 |